TPX2 and adrenal cortex carcinoma: Patients with TPX2 overexpression had lower DSS for ACC, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PAAD, PCPG, SKCM, and UCEC (Figure 3(b)).